(Q37961911)

26 August 2017

title

Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost-effectiveness (English)

1 reference

cost-effectiveness analysis

26 August 2017

0 references

1 reference

Elisa Sicuri

3

0 references

Maurits W van Tulder

object named as

Maurits van Tulder

series ordinal

4

0 references

Martin Peter Grobusch

series ordinal

5

object named as

Martin P Grobusch

1 reference

26 August 2017

1

Michèle van Vugt

1 reference

26 August 2017

Anne van Beest

2

1 reference

26 August 2017

publication date

1 December 2011

1 reference

26 August 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

26 August 2017

volume

6

1 reference

26 August 2017

issue

12

1 reference

26 August 2017

page(s)

1485-1500

1 reference

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

The economic and social burden of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of artesunate for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Early rectal artesunate administration: a life-saver in remote areas?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

An economic evaluation of home management of malaria in Uganda: an interactive Markov model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Imported cases of malaria admitted to two hospitals of Margarita Island, Venezuela, 1998-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Malaria transmission in non-endemic areas: case report, review of the literature and implications for public health management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness study of three antimalarial drug combinations in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness ratio of using rapid tests for malaria diagnosis in the Peruvian Amazon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Modeling the risk of malaria for travelers to areas with stable malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.138

21 January 2018

Identifiers

DOI

10.2217/FMB.11.138

1 reference

26 August 2017

1 reference